Fundz

Dechra acquires Gallant Pet, Inc. for growth

PRIVATENov 17, 2026

Acquiring Company

Dechra

Acquired Company

Gallant

BostonSan DiegoHealth CareAnimal FeedPetVeterinaryOtherBiotechnologyHealth CareTherapeutics

Description

Dechra has completed its acquisition of Gallant Pet, Inc., an animal health biotechnology company. This strategic move aims to enhance veterinary care through regenerative medicine and broaden treatment options for complex conditions in pets.

Other recent acquisitions in Animal Feed and Pet

Deals where the buyer or target shares a sector with this one, within 45 days, from Fundz verified event records.

Who to call at Dechra, and when

When Dechra changes hands, the new owners review vendors, systems and leadership. That is when the door opens.

  • An alert the day Dechra raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Dechra, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Dechra. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Dechra

Location

Boston, Massachusetts, United States

About

Dechra is a global leader in veterinary specialty care, dedicated to making a difference in animal health through purpose-built solutions and trusted partnerships that support veterinarian professionals, pet parents, horse owners, and the animals they care for.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Dechra makes an acquisition, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Predictive Intelligence
Strategic

ML-powered predictions for Dechra's next move

Learn about Strategic plan

Frequently asked

Who acquired Gallant?

Gallant was acquired by Dechra, based in Boston. The deal was reported on November 17, 2026. Dechra is privately held and operates in Health Care.

When did Dechra acquire Gallant?

Dechra's acquisition of Gallant was reported on November 17, 2026. Dechra has completed its acquisition of Gallant Pet, Inc., an animal health biotechnology company. This strategic move aims to enhance veterinary care through regenerative medicine and broaden treatment options for complex conditions in pets. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.

What does Gallant do?

Gallant is a regenerative medicine company pioneering veterinary therapies that restore health at the source. It is privately held, operating in Other, and is based in San Diego.

This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.